290 related articles for article (PubMed ID: 20828147)
1. The conformation and the aggregation kinetics of α-synuclein depend on the proline residues in its C-terminal region.
Meuvis J; Gerard M; Desender L; Baekelandt V; Engelborghs Y
Biochemistry; 2010 Nov; 49(43):9345-52. PubMed ID: 20828147
[TBL] [Abstract][Full Text] [Related]
2. The aggregation of alpha-synuclein is stimulated by FK506 binding proteins as shown by fluorescence correlation spectroscopy.
Gerard M; Debyser Z; Desender L; Kahle PJ; Baert J; Baekelandt V; Engelborghs Y
FASEB J; 2006 Mar; 20(3):524-6. PubMed ID: 16410343
[TBL] [Abstract][Full Text] [Related]
3. Impact of the acidic C-terminal region comprising amino acids 109-140 on alpha-synuclein aggregation in vitro.
Hoyer W; Cherny D; Subramaniam V; Jovin TM
Biochemistry; 2004 Dec; 43(51):16233-42. PubMed ID: 15610017
[TBL] [Abstract][Full Text] [Related]
4. Calcium-triggered membrane interaction of the alpha-synuclein acidic tail.
Tamamizu-Kato S; Kosaraju MG; Kato H; Raussens V; Ruysschaert JM; Narayanaswami V
Biochemistry; 2006 Sep; 45(36):10947-56. PubMed ID: 16953580
[TBL] [Abstract][Full Text] [Related]
5. Acceleration of alpha-synuclein aggregation by homologous peptides.
Du HN; Li HT; Zhang F; Lin XJ; Shi JH; Shi YH; Ji LN; Hu J; Lin DH; Hu HY
FEBS Lett; 2006 Jun; 580(15):3657-64. PubMed ID: 16764865
[TBL] [Abstract][Full Text] [Related]
6. In vitro phosphorylation does not influence the aggregation kinetics of WT α-synuclein in contrast to its phosphorylation mutants.
Schreurs S; Gerard M; Derua R; Waelkens E; Taymans JM; Baekelandt V; Engelborghs Y
Int J Mol Sci; 2014 Jan; 15(1):1040-67. PubMed ID: 24434619
[TBL] [Abstract][Full Text] [Related]
7. A peptide motif consisting of glycine, alanine, and valine is required for the fibrillization and cytotoxicity of human alpha-synuclein.
Du HN; Tang L; Luo XY; Li HT; Hu J; Zhou JW; Hu HY
Biochemistry; 2003 Jul; 42(29):8870-8. PubMed ID: 12873148
[TBL] [Abstract][Full Text] [Related]
8. Isomers of human alpha-synuclein stabilized by disulfide bonds exhibit distinct structural and aggregative properties.
Jiang C; Chang JY
Biochemistry; 2007 Jan; 46(2):602-9. PubMed ID: 17209570
[TBL] [Abstract][Full Text] [Related]
9. The role of the C-terminus of human α-synuclein: intra-disulfide bonds between the C-terminus and other regions stabilize non-fibrillar monomeric isomers.
Hong DP; Xiong W; Chang JY; Jiang C
FEBS Lett; 2011 Feb; 585(3):561-6. PubMed ID: 21237164
[TBL] [Abstract][Full Text] [Related]
10. Studies of the aggregation of an amyloidogenic alpha-synuclein peptide fragment.
Madine J; Doig AJ; Kitmitto A; Middleton DA
Biochem Soc Trans; 2005 Nov; 33(Pt 5):1113-5. PubMed ID: 16246058
[TBL] [Abstract][Full Text] [Related]
11. Proline residues in transmembrane alpha helices affect the folding of bacteriorhodopsin.
Lu H; Marti T; Booth PJ
J Mol Biol; 2001 Apr; 308(2):437-46. PubMed ID: 11327778
[TBL] [Abstract][Full Text] [Related]
12. Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease.
Conway KA; Harper JD; Lansbury PT
Nat Med; 1998 Nov; 4(11):1318-20. PubMed ID: 9809558
[TBL] [Abstract][Full Text] [Related]
13. Site-specific fluorescence dynamics of α-synuclein fibrils using time-resolved fluorescence studies: effect of familial Parkinson's disease-associated mutations.
Sahay S; Anoop A; Krishnamoorthy G; Maji SK
Biochemistry; 2014 Feb; 53(5):807-9. PubMed ID: 24450731
[TBL] [Abstract][Full Text] [Related]
14. FK506 binding protein 12 differentially accelerates fibril formation of wild type alpha-synuclein and its clinical mutants A30P or A53T.
Gerard M; Debyser Z; Desender L; Baert J; Brandt I; Baekelandt V; Engelborghs Y
J Neurochem; 2008 Jul; 106(1):121-33. PubMed ID: 18346205
[TBL] [Abstract][Full Text] [Related]
15. alpha -Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson's disease.
Lo Bianco C; Ridet JL; Schneider BL; Deglon N; Aebischer P
Proc Natl Acad Sci U S A; 2002 Aug; 99(16):10813-8. PubMed ID: 12122208
[TBL] [Abstract][Full Text] [Related]
16. Altered ion channel formation by the Parkinson's-disease-linked E46K mutant of alpha-synuclein is corrected by GM3 but not by GM1 gangliosides.
Di Pasquale E; Fantini J; Chahinian H; Maresca M; Taïeb N; Yahi N
J Mol Biol; 2010 Mar; 397(1):202-18. PubMed ID: 20114052
[TBL] [Abstract][Full Text] [Related]
17. Cleavage of normal and pathological forms of alpha-synuclein by neurosin in vitro.
Kasai T; Tokuda T; Yamaguchi N; Watanabe Y; Kametani F; Nakagawa M; Mizuno T
Neurosci Lett; 2008 May; 436(1):52-6. PubMed ID: 18358605
[TBL] [Abstract][Full Text] [Related]
18. Molecular insights into the interaction between alpha-synuclein and docosahexaenoic acid.
De Franceschi G; Frare E; Bubacco L; Mammi S; Fontana A; de Laureto PP
J Mol Biol; 2009 Nov; 394(1):94-107. PubMed ID: 19747490
[TBL] [Abstract][Full Text] [Related]
19. Multiple roles of prolyl residues in structure and folding.
Eyles SJ; Gierasch LM
J Mol Biol; 2000 Aug; 301(3):737-47. PubMed ID: 10966780
[TBL] [Abstract][Full Text] [Related]
20. Inhibiting aggregation of alpha-synuclein with human single chain antibody fragments.
Emadi S; Liu R; Yuan B; Schulz P; McAllister C; Lyubchenko Y; Messer A; Sierks MR
Biochemistry; 2004 Mar; 43(10):2871-8. PubMed ID: 15005622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
